Patient Demographics
| Demographic | UWCCC | MSKCC | NCI |
| Patients (n) | 18 | 11 | 6 |
| Age (y) | |||
| Median | 72.5 | 75.0 | 68 |
| Range | 47–87 | 57–81 | 57–83 |
| Height (cm) | |||
| Median | 178 | 177 | 171 |
| Range | 166–191 | 162–191 | 161–189 |
| Weight (kg) | |||
| Median | 92.3 | 94.0 | 84.6 |
| Range | 70.7–145.0 | 73.0–119.0 | 75.4–91.6 |
| PSA | |||
| Median | 71.2 | 8.1 | 85.9 |
| Range | 1.6–310.0 | 2.5–246.8 | 32.0–460.7 |
| Gleason score (n) | |||
| 6 | 1 (6%) | 2 (18%) | 1 (17%) |
| 7 | 7 (39%) | 5 (45%) | 2 (33%) |
| 8 | 4 (22%) | 1 (9%) | 2 (33%) |
| 9 | 3 (17%) | 3 (27%) | 1 (17%) |
| LDH (U/L) | |||
| Median | 200 | 219 | 264 |
| Range | 139–470 | 157–251 | 119–903 |
| Hemoglobin (g/dL) | |||
| Median | 12.8 | 13.8 | 11.8 |
| Range | 7.7–14.9 | 11.3–15.3 | 9.0–13.9 |
| Lesions (n) | |||
| ≤5 | 6 (33%) | 5 (45%) | 2 (33%) |
| 6–10 | 0 (0%) | 4 (36%) | 1 (17%) |
| 11–20 | 10 (56%) | 2 (18%) | 2 (33%) |
| 20 | 2 (11%) | 0 (0%) | 1 (17%) |
PSA = prostate-specific antigen; LDH = lactic acid dehydrogenase.